CEO Executive AssistantTechnology vendor relationships have become one of the most significant and least well-managed time demands in the health system CEO portfolio. As clinical and administrative technology has proliferated, the number of vendors seeking CEO-level engagement has grown dramatically. Electronic health record companies, revenue cycle management vendors, population health technology platforms, cybersecurity firms, AI and analytics companies, telehealth platforms, and clinical decision support vendors all compete for executive attention. The result, for CEOs who do not manage these relationships deliberately, is a calendar fragmented by vendor meetings that produce limited strategic value and significant opportunity cost.
The most effective health system CEOs have developed explicit frameworks for vendor relationship management that extract genuine strategic value from the most important relationships while efficiently declining the rest.
Why Vendors Want CEO Access
Understanding why technology vendors pursue CEO relationships clarifies which requests are worth honoring and which are not.
Some vendors genuinely benefit from CEO engagement: their products have strategic implications for the health system that require CEO-level understanding and authorization, and their organizational decision-making benefits from direct access to the health system’s strategic leader. These are relationships worth investing in.
Most vendor requests for CEO time, however, are driven by sales and account management objectives rather than genuine strategic need. A CEO meeting validates the relationship for the vendor’s internal account management team, helps the vendor close deals or renewals, and creates the impression of strategic partnership without necessarily advancing the health system’s strategic objectives.
This does not mean all vendor-initiated requests should be declined. It means the CEO should evaluate each request against a genuine question: Does my personal involvement in this relationship create value for the health system that cannot be created by my CIO, COO, or procurement team? If the answer is no, the CEO should not be in the meeting.
Building Your Vendor Engagement Framework
A practical vendor engagement framework for health system CEOs has three tiers based on strategic importance and relationship level.
Tier 1: Strategic partners. These are the vendors whose technology is foundational to your health system’s clinical and operational model, whose performance directly affects patient care quality, and whose organizations are investing in the same strategic direction you are pursuing. Your EHR vendor and two or three other foundational technology partners typically belong in this tier.
For Tier 1 vendors, invest in a genuine CEO-level relationship: an annual strategic meeting with the vendor’s CEO or president, a quarterly executive check-in, and direct communication channels for the rare occasions when a significant issue requires CEO-to-CEO engagement. These relationships are worth CEO time because the vendor’s decisions can affect your strategic trajectory, and your voice at the CEO level has the most influence on those decisions.
Tier 2: Important but operationally managed vendors. These are significant vendors whose performance matters to your operations but whose relationships can be managed primarily at the CIO, COO, or VP level without material strategic loss. Most of your major technology vendors belong here.
For Tier 2 vendors, the CEO’s engagement is occasional rather than regular: an annual meeting to review the strategic relationship and address any significant concerns, with all other engagement handled by your operational leaders. Your involvement is available for escalations but is not the default relationship management model.
Tier 3: Standard commercial relationships. These vendors provide useful services but have no unique strategic relationship with your organization. CEO engagement is not appropriate for this tier. All relationship management belongs to procurement and operational teams.
Apply this tiering annually with your CIO and COO, updating the assignment of major vendors as your technology portfolio and strategic priorities evolve.
Managing the Inbound Vendor Request Volume
Health system CEOs receive a substantial volume of vendor meeting requests, particularly from technology vendors who target healthcare at the executive level. Managing this volume requires both a filter framework and an EA who applies it consistently.
Define your vendor meeting acceptance criteria explicitly: Which vendor meeting requests should be automatically accepted, routed to another executive, or declined? The criteria should reflect your tiering framework plus a set of specific circumstances that warrant CEO involvement independent of tier (a significant contract negotiation, a material service failure requiring executive resolution, or a strategic innovation conversation with a vendor in an area of active organizational interest).
Your executive assistant for healthcare CEO should apply these criteria as the first filter on all vendor meeting requests, accepting those that meet the criteria, routing those that belong to other executives, and gracefully declining those that do not meet either standard. A brief, professional decline note that suggests an appropriate operational contact maintains relationship courtesy without consuming CEO time.
Making Vendor Meetings Productive
When you do invest in a vendor meeting, make it count. CEO time with a vendor should advance strategic objectives, not serve as a repeat of information available from operational reviews.
Prepare specifically for vendor meetings: what is the health system’s current state with this vendor’s technology? What are the three most important strategic questions you want to address? What decisions or commitments are you prepared to make? Brief preparation, five to ten minutes reviewing a pre-meeting note from your CIO, dramatically improves the quality of executive vendor conversations.
Set an agenda for every CEO vendor meeting, shared in advance. The agenda signals that your time is structured and purposeful, shapes the vendor’s preparation to be relevant, and allows the meeting to produce decisions rather than simply conversation.
Follow up specifically on CEO-level commitments from vendor meetings. If you committed to review a proposal, make an introduction, or communicate a decision, execute those commitments through your EA within 48 hours. This follow-through quality defines the relationship value for both parties.
The Innovation Scouting Function
One legitimate and high-value reason for health system CEOs to maintain a broader range of vendor conversations is innovation scouting: staying aware of emerging technologies, business models, and clinical applications that may have strategic relevance for your organization’s future.
This function is different from account management meetings with existing vendors. Innovation scouting involves meeting with emerging health tech companies, attending healthcare technology conferences, and maintaining relationships with venture investors and innovators who can surface relevant emerging technologies.
Reserve a quarterly innovation meeting slot: a 60-minute conversation with one or two emerging technology companies whose innovation may be strategically relevant in two to five years. These meetings are not procurement discussions. They are strategic intelligence investments that keep you aware of how the technology landscape is evolving.
Deloitte’s health system technology research consistently identifies proactive technology scouting by health system leadership as a differentiating factor between organizations that adopt advantageous technologies early and those that adopt them reactively after competitive pressure forces the decision.
The Board’s Technology Governance Role
Your board has a governance interest in your health system’s technology strategy, particularly given the capital commitment of major system implementations and the cybersecurity risk exposure that technology creates. Managing the board’s technology governance engagement is a CEO time demand that requires structure.
Provide the board with an annual technology strategy review: a 30-minute presentation covering your technology portfolio, major investments and their performance, cybersecurity posture and risk management, and the major technology decisions coming in the next year. This structured annual review satisfies the board’s technology oversight need without requiring multiple separate technology discussions at different board meetings.
Maintain a standing cybersecurity briefing cadence with your board’s audit or risk committee, given the high-profile nature of healthcare cybersecurity incidents. A quarterly 30-minute briefing keeps the board appropriately informed without consuming board meeting time with technology detail.
Protecting Strategic IT Investment Decisions
The CEO’s most important role in technology vendor relationships is ensuring that major technology investments are driven by strategic necessity rather than vendor relationship management. It is easy for health systems to accumulate technology investments driven by individual departmental requests, vendor sales effectiveness, or peer pressure from board members who have seen another health system’s technology adoption, rather than by a coherent technology strategy aligned with organizational goals.
Establish an annual technology investment review as a CEO-level governance activity: a structured process where your CIO presents the proposed technology investment portfolio for the coming year and you and your leadership team evaluate it against the health system’s strategic priorities, financial constraints, and operational capacity.
Apply calendar management for hospital CEOs principles to protect this review in your annual calendar, ensuring it receives the preparation and deliberation it deserves rather than being compressed into a budget meeting footnote.
Technology vendors will lobby for their projects through multiple organizational channels: board members, clinical leaders, and operational champions. The CEO who has a structured strategic technology review process can evaluate these proposals coherently rather than being influenced by the most recent or most persistent advocate.
The Long-Term Vendor Relationship Perspective
Health system technology relationships have long lifecycles. Major EHR systems are in place for ten to twenty years. Revenue cycle vendors develop deep operational integration. Population health platforms become embedded in clinical workflows. The CEO’s approach to these long-term relationships significantly affects the organization’s ability to extract full strategic value from major technology investments.
Invest in the relationship quality with your most strategic long-term vendors not as a vendor management practice but as a strategic asset development practice. Vendors who have genuine CEO relationships with your health system are more likely to prioritize your organization for innovation previews, to address service issues with genuine urgency, and to provide favorable terms in contract renewals.
This relationship investment, structured and appropriately bounded, is one of the more valuable uses of the health system CEO’s limited external relationship time.
Related Reading
For further context, explore How Health System CEOs Allocate Time for Physician Recruitment and Retention and How Health System CEOs Manage Board and Governance Responsibilities Efficiently.